Generated by GPT-5-mini| Article 265 TFEU | |
|---|---|
| Title | Article 265 TFEU |
| Type | Treaty provision |
| Jurisdiction | European Union |
| Adopted | Treaty of Lisbon |
| Provisions | Preventive annulment by the Court of Justice |
Article 265 TFEU
Article 265 TFEU provides a preventive remedy allowing institutions and other EU actors to seek a declaration that an act of an institution, body, office or agency is not intended to produce legal effects, and to obtain a declaration to ensure that no legal effects arise, situated within the framework of the Treaty on the Functioning of the European Union, the Court of Justice of the European Union, and the constitutional order of the European Union. The provision interacts with broader EU instruments such as the Treaty of Maastricht, the Treaty of Nice, and the Charter of Fundamental Rights of the European Union, and operates alongside remedies like the action for annulment and the action for failure to act.
The text appears in Title VI of Part Six of the Treaty on the Functioning of the European Union as an autonomous provision addressing non-contractual preventive relief available before the Court of Justice of the European Union and the General Court (European Union). The wording complements articles such as those establishing the European Commission, the Council of the European Union, and the European Parliament, situating preventive jurisdiction within the architecture created by the Treaty of Rome amendments culminating in the Treaty of Lisbon.
Article 265 TFEU is designed to protect the legal order established by instruments like the Single European Act and the Maastricht Treaty by allowing timely judicial scrutiny of acts that may purport to create rights or obligations affecting entities such as the European Central Bank, the European Investment Bank, or the European Court of Auditors. It operates in the institutional ecosystem alongside remedies under the Treaty Establishing the European Atomic Energy Community and interacts with principles developed by the European Court of Human Rights and the International Court of Justice in matters of preventive judicial review. The provision reinforces remedies available under the CJEU jurisprudence stemming from cases such as litigation involving the European Commission and the Council of Ministers.
The scope encompasses acts of institutions, bodies, offices, or agencies of the European Union that are not intended to produce legal effects but nonetheless may do so or create uncertainty, implicating organs like the European External Action Service or agencies such as the European Medicines Agency and the European Aviation Safety Agency. Eligible applicants include the European Commission, member states like France, Germany, and Italy, and other EU actors recognized by the Court of Justice of the European Union. Conditions for admissibility draw on jurisdictional criteria developed in cases involving the European Parliament and the Council of the European Union, and reflect procedural principles shared with the action for annulment and the action for failure to act.
Procedural rules derive from the Statute of the Court of Justice of the European Union and the Rules of Procedure of the General Court (European Union), with parties including the European Commission, the European Central Bank, and member states represented in litigation through agents, advocates like those appearing before the European Court of Human Rights and procedural figures such as the Advocate General of the Court of Justice of the European Union. Remedies include declaratory judgments that an act is not intended to produce legal effects and orders ensuring no legal effects arise, analogous to remedies awarded in actions under the action for annulment framework and consistent with principles articulated in precedent by judges influenced by doctrines from the International Court of Justice and administrative tribunals in jurisdictions like the Court of Appeal (England and Wales).
The Court of Justice of the European Union and the General Court (European Union) have interpreted Article 265 TFEU in light of prominent rulings concerning institutional acts by the European Commission, the Council of the European Union, and agencies such as the European Medicines Agency. Jurisprudence references decisions involving member states including Spain, Poland, and Netherlands, and engages with doctrines from case law addressing admissibility, standing, and the justiciability of preparatory acts as seen in earlier precedent connected to the European Coal and Steel Community and subsequent treaty evolutions like the Treaty of Amsterdam.
Comparatively, Article 265 TFEU is analyzed alongside preventive remedies in federal systems such as the United States Supreme Court practice, the German Federal Constitutional Court, and the Supreme Court of Canada, highlighting differences in standing, remedies, and timing. Practically, the provision matters for entities like the European Investment Bank and regulatory agencies including the European Securities and Markets Authority when clarifying the legal effects of communications, guidelines, or preparatory measures, and it informs litigation strategies employed by member states such as Belgium or institutions like the European Parliament when seeking to preserve legal certainty within the European Union legal order.